• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合分子对接和分子动力学预测黄酮类衍生物与2009年甲型H1N1流感病毒神经氨酸酶的结合模式。

Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus.

作者信息

Lu Shih-Jen, Chong Fok-Ching

机构信息

Department of Electrical Engineering, National Taiwan University, Taipei 10617, Taiwan.

Department of Research and Development, BroadMaster Biotech Co., Ltd.: 7F., No.168-2, Liancheng Rd., Zhonghe Dist., New Taipei City 23553, Taiwan.

出版信息

Int J Mol Sci. 2012;13(4):4496-4507. doi: 10.3390/ijms13044496. Epub 2012 Apr 10.

DOI:10.3390/ijms13044496
PMID:22605992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3344228/
Abstract

Control of flavonoid derivatives inhibitors release through the inhibition of neuraminidase has been identified as a potential target for the treatment of H1N1 influenza disease. We have employed molecular dynamics simulation techniques to optimize the 2009 H1N1 influenza neuraminidase X-ray crystal structure. Molecular docking of the compounds revealed the possible binding mode. Our molecular dynamics simulations combined with the solvated interaction energies technique was applied to predict the docking models of the inhibitors in the binding pocket of the H1N1 influenza neuraminidase. In the simulations, the correlation of the predicted and experimental binding free energies of all 20 flavonoid derivatives inhibitors is satisfactory, as indicated by R(2) = 0.75.

摘要

通过抑制神经氨酸酶来控制类黄酮衍生物抑制剂的释放已被确定为治疗H1N1流感疾病的一个潜在靶点。我们采用分子动力学模拟技术对2009年H1N1流感神经氨酸酶的X射线晶体结构进行了优化。化合物的分子对接揭示了可能的结合模式。我们将分子动力学模拟与溶剂化相互作用能技术相结合,用于预测抑制剂在H1N1流感神经氨酸酶结合口袋中的对接模型。在模拟中,所有20种类黄酮衍生物抑制剂的预测结合自由能与实验结合自由能之间的相关性令人满意,R(2) = 0.75表明了这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/244487039b36/ijms-13-04496f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/482391d64310/ijms-13-04496f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/6689c1c67287/ijms-13-04496f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/244487039b36/ijms-13-04496f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/482391d64310/ijms-13-04496f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/6689c1c67287/ijms-13-04496f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d30/3344228/244487039b36/ijms-13-04496f3.jpg

相似文献

1
Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus.结合分子对接和分子动力学预测黄酮类衍生物与2009年甲型H1N1流感病毒神经氨酸酶的结合模式。
Int J Mol Sci. 2012;13(4):4496-4507. doi: 10.3390/ijms13044496. Epub 2012 Apr 10.
2
Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.抗流感药物在甲型H1N1(2009)和H5N1流感病毒中的结合模式分析及潜在H1N1抑制剂的设计
Int J Comput Biol Drug Des. 2015;8(1):1-18. doi: 10.1504/IJCBDD.2015.068753. Epub 2015 Apr 13.
3
Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.通过分子动力学模拟和自由能计算深入了解 2009 年甲型流感(H1N1)神经氨酸酶 E119G 突变体对抗病毒药物的敏感性。
Antiviral Res. 2013 Nov;100(2):356-64. doi: 10.1016/j.antiviral.2013.09.006. Epub 2013 Sep 19.
4
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.黄酮类衍生物对流感病毒神经氨酸酶的抑制效力。
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4312-7. doi: 10.1016/j.bmcl.2014.07.010. Epub 2014 Jul 18.
5
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.三维定量构效关系和对接研究黄酮衍生物作为流感 H1N1 病毒神经氨酸酶的有效抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5964-70. doi: 10.1016/j.bmcl.2011.07.071. Epub 2011 Jul 26.
6
Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.作为强效抗流感药物的取代扎那米韦衍生物的分子建模与先导设计
BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1.
7
Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.新型扎那米韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3622-3629. doi: 10.1016/j.bmcl.2018.10.040. Epub 2018 Oct 26.
8
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.利用多维计算分析理解奥司他韦对甲型H1N1和H5N1流感神经氨酸酶突变的交叉耐药性。
Drug Des Devel Ther. 2015 Jul 31;9:4137-54. doi: 10.2147/DDDT.S81934. eCollection 2015.
9
3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.3D 定量构效关系及姜黄素衍生物抗流感 H1N1 神经氨酸酶活性的研究
Arch Pharm Res. 2020 May;43(5):489-502. doi: 10.1007/s12272-020-01230-5. Epub 2020 Apr 4.
10
The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.花色苷-3-桑布比定对 H1N1 流感病毒 H274Y 突变的抑制作用。
J Biomol Struct Dyn. 2018 Dec;36(16):4255-4269. doi: 10.1080/07391102.2017.1413422. Epub 2017 Dec 20.

引用本文的文献

1
The effect of Leaves' extract for mild and asymptomatic corona virus Disease-19.树叶提取物对轻度和无症状冠状病毒病-19的影响。
Saudi Pharm J. 2023 Apr;31(4):592-596. doi: 10.1016/j.jsps.2023.02.012. Epub 2023 Mar 7.
2
In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.通过二维定量构效关系(2D-QSAR)、三维定量构效关系(3D-QSAR)、分子对接和药物代谢及毒性预测(ADMET)对5-苄基-4-噻唑啉酮衍生物作为流感神经氨酸酶抑制剂进行计算机模拟研究。
Heliyon. 2022 Aug 8;8(8):e10101. doi: 10.1016/j.heliyon.2022.e10101. eCollection 2022 Aug.
3

本文引用的文献

1
Characterization of avian influenza viruses isolated from domestic ducks in Vietnam in 2009 and 2010.2009 年和 2010 年越南从家养鸭中分离出的禽流感病毒的特性。
Arch Virol. 2012 Feb;157(2):247-57. doi: 10.1007/s00705-011-1152-3. Epub 2011 Nov 9.
2
Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.结构与功能分析兰尼纳韦及其辛酸酯前药揭示流感神经氨酸酶抑制的基团特异性机制。
PLoS Pathog. 2011 Oct;7(10):e1002249. doi: 10.1371/journal.ppat.1002249. Epub 2011 Oct 20.
3
Influenza neuraminidase: a druggable target for natural products.
Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset.
鉴定针对 SARS-CoV-2 结构和非结构蛋白靶标的潜在抗病毒化合物:CAS COVID-19 数据集的药物信息学研究。
Comput Biol Med. 2021 Jun;133:104364. doi: 10.1016/j.compbiomed.2021.104364. Epub 2021 Apr 19.
4
Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies.对呼吸道病毒有活性的植物源食品级物质(PDFGS):非临床研究的系统评价
Front Nutr. 2021 Feb 9;8:606782. doi: 10.3389/fnut.2021.606782. eCollection 2021.
5
Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.黄酮类衍生物作为甲型流感病毒H1N1神经氨酸酶有效抑制剂的对接研究
Biomed Rep. 2019 Jan;10(1):33-38. doi: 10.3892/br.2018.1173. Epub 2018 Nov 23.
6
Flavonoids: an overview.黄酮类化合物:综述。
J Nutr Sci. 2016 Dec 29;5:e47. doi: 10.1017/jns.2016.41. eCollection 2016.
7
Machine-learning techniques applied to antibacterial drug discovery.应用于抗菌药物发现的机器学习技术。
Chem Biol Drug Des. 2015 Jan;85(1):14-21. doi: 10.1111/cbdd.12423.
8
Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors.色氨酸羟化酶-1的分子动力学模拟:与苯丙氨酸衍生物抑制剂的结合模式及自由能分析
Int J Mol Sci. 2013 May 10;14(5):9947-62. doi: 10.3390/ijms14059947.
流感神经氨酸酶:天然产物的可成药靶标。
Nat Prod Rep. 2012 Jan;29(1):11-36. doi: 10.1039/c1np00053e. Epub 2011 Oct 25.
4
NNScore 2.0: a neural-network receptor-ligand scoring function.NNScore 2.0:一种神经网络受体配体评分函数。
J Chem Inf Model. 2011 Nov 28;51(11):2897-903. doi: 10.1021/ci2003889. Epub 2011 Nov 3.
5
Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.氨基酸变化导致血凝素对奥司他韦耐药的 H1N1 流感病毒的复制。
J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.
6
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets.对具有神经氨酸酶 I223R 突变的 2009 年 A/H1N1 流感耐药临床分离株进行研究,结果表明其在雪貂中仍保持毒力和传染性。
PLoS Pathog. 2011 Sep;7(9):e1002276. doi: 10.1371/journal.ppat.1002276. Epub 2011 Sep 29.
7
Parenteral peramivir treatment for Oseltamivir-resistant 2009 pandemic influenza A H1N1 viruses.采用帕拉米韦肠外给药治疗对奥司他韦耐药的2009年甲型H1N1大流行性流感病毒感染。
J Infect Dis. 2011 Nov 15;204(10):1641-2; author's reply 1642-3. doi: 10.1093/infdis/jir610. Epub 2011 Sep 23.
8
Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.基于分子动力学的碳环神经氨酸酶抑制剂的 CoMFA 研究。
Mol Divers. 2011 Nov;15(4):979-87. doi: 10.1007/s11030-011-9332-3. Epub 2011 Sep 16.
9
Mechanism of 150-cavity formation in influenza neuraminidase.流感神经氨酸酶中 150 腔形成的机制。
Nat Commun. 2011 Jul 12;2:388. doi: 10.1038/ncomms1390.
10
Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.神经氨酸酶抑制剂 R-125489——治疗流感病毒的有前途药物:导向分子动力学方法。
Biochem Biophys Res Commun. 2011 Jul 8;410(3):688-91. doi: 10.1016/j.bbrc.2011.06.057. Epub 2011 Jun 12.